Vaccine Safety: Assessing the Prevalence and Severity of Adverse Events Following COVID-19 Vaccination amongst Healthcare Workers in Tertiary Health Facilities in Nigeria.

IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL Nigerian Postgraduate Medical Journal Pub Date : 2024-01-01 Epub Date: 2024-02-07 DOI:10.4103/npmj.npmj_227_23
Ayotunde Sherif Azees, Mojirola Martina Fasiku, Abdulfattah Isa, Ahuna Zainab Ezenwoko, Abdullahi Ahmed, Abiola Oluwatoyin Temitayo-Oboh, Rowland Utulu, Makinde Adebayo Adeniyi, Abubakar Musa, Chihurumnanya Alo, Usman Muhammed Ibrahim, Gloria Bosede Imhonopi, Oluwaseun Opeyemi Adesoye, Ifeyinwa Maureen Okeke, Godwin ThankGod John, Abdulquadri Yeketi Ayinla
{"title":"Vaccine Safety: Assessing the Prevalence and Severity of Adverse Events Following COVID-19 Vaccination amongst Healthcare Workers in Tertiary Health Facilities in Nigeria.","authors":"Ayotunde Sherif Azees, Mojirola Martina Fasiku, Abdulfattah Isa, Ahuna Zainab Ezenwoko, Abdullahi Ahmed, Abiola Oluwatoyin Temitayo-Oboh, Rowland Utulu, Makinde Adebayo Adeniyi, Abubakar Musa, Chihurumnanya Alo, Usman Muhammed Ibrahim, Gloria Bosede Imhonopi, Oluwaseun Opeyemi Adesoye, Ifeyinwa Maureen Okeke, Godwin ThankGod John, Abdulquadri Yeketi Ayinla","doi":"10.4103/npmj.npmj_227_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Vaccines, including COVID-19 vaccines, are known to be cost-effective interventions for disease prevention and control. However, adverse events following immunisation (AEFI) may challenge the acceptance of these vaccines. This study assessed the prevalence and severity of COVID-19-related AEFI amongst healthcare workers at tertiary health facilities in Nigeria.</p><p><strong>Materials and methods: </strong>This descriptive, cross-sectional study was conducted among healthcare workers who had received the COVID-19 vaccine. A multi-stage sampling technique was used to select participants from six Tertiary Health Facilities in Nigeria. Ethical approval (NHREC/01/01/2007-19/07/2021) was obtained from NHREC. Data were analysed using IBM® SPSS version 25 and categorical variables were presented in tables/charts using frequencies and proportions.</p><p><strong>Results: </strong>A total of 2130 respondents participated in the study, with a mean age of 37.4 ± 9.1 years. Most of the respondents, 1674 (78.6%), had two doses of the vaccine, and the overall prevalence of AEFI was 813 (38.2%). Common among the AEFI reported following the administration of the first dose of the vaccine were fever 649 (30.5%) and pain at the injection site 644 (30.2%), while it was pain at the injection site 216 (10.1%) and fever 173 (8.1%) for second dose. The higher proportions of AEFI were mostly mild to moderate.</p><p><strong>Conclusion: </strong>The study observed a relatively low prevalence of AEFI, with the commonly reported ones being fever and injection site pain. It is crucial that countries continuously collect the data on AEFI and establish causality as a way to improve quality and guarantee vaccine safety.</p>","PeriodicalId":19720,"journal":{"name":"Nigerian Postgraduate Medical Journal","volume":"31 1","pages":"1-7"},"PeriodicalIF":0.8000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nigerian Postgraduate Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/npmj.npmj_227_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/7 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Vaccines, including COVID-19 vaccines, are known to be cost-effective interventions for disease prevention and control. However, adverse events following immunisation (AEFI) may challenge the acceptance of these vaccines. This study assessed the prevalence and severity of COVID-19-related AEFI amongst healthcare workers at tertiary health facilities in Nigeria.

Materials and methods: This descriptive, cross-sectional study was conducted among healthcare workers who had received the COVID-19 vaccine. A multi-stage sampling technique was used to select participants from six Tertiary Health Facilities in Nigeria. Ethical approval (NHREC/01/01/2007-19/07/2021) was obtained from NHREC. Data were analysed using IBM® SPSS version 25 and categorical variables were presented in tables/charts using frequencies and proportions.

Results: A total of 2130 respondents participated in the study, with a mean age of 37.4 ± 9.1 years. Most of the respondents, 1674 (78.6%), had two doses of the vaccine, and the overall prevalence of AEFI was 813 (38.2%). Common among the AEFI reported following the administration of the first dose of the vaccine were fever 649 (30.5%) and pain at the injection site 644 (30.2%), while it was pain at the injection site 216 (10.1%) and fever 173 (8.1%) for second dose. The higher proportions of AEFI were mostly mild to moderate.

Conclusion: The study observed a relatively low prevalence of AEFI, with the commonly reported ones being fever and injection site pain. It is crucial that countries continuously collect the data on AEFI and establish causality as a way to improve quality and guarantee vaccine safety.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
疫苗安全:评估尼日利亚三级医疗机构医护人员接种 COVID-19 疫苗后不良事件的发生率和严重程度。
背景:众所周知,包括 COVID-19 疫苗在内的疫苗是具有成本效益的疾病预防和控制干预措施。然而,免疫接种后的不良反应(AEFI)可能会影响人们对这些疫苗的接受程度。本研究评估了尼日利亚三级医疗机构医护人员中与 COVID-19 疫苗相关的 AEFI 的发生率和严重程度:这项描述性横断面研究在接种过 COVID-19 疫苗的医护人员中进行。研究采用多阶段抽样技术,从尼日利亚的六家三级医疗机构中挑选参与者。研究获得了尼日利亚国家卫生与健康委员会的伦理批准(NHREC/01/01/2007-19/07/2021)。数据使用 IBM® SPSS 第 25 版进行分析,分类变量使用频率和比例以表格/图表的形式呈现:共有 2130 名受访者参与了研究,平均年龄为 37.4 ± 9.1 岁。大多数受访者(1674 人(78.6%))接种过两剂疫苗,AEFI 的总发病率为 813 人(38.2%)。在接种第一剂疫苗后报告的 AEFI 中,常见的是发烧 649 例(30.5%)和注射部位疼痛 644 例(30.2%),而接种第二剂疫苗时,常见的是注射部位疼痛 216 例(10.1%)和发烧 173 例(8.1%)。较高比例的 AEFI 多为轻度至中度:研究发现,AEFI 的发生率相对较低,常见的是发烧和注射部位疼痛。至关重要的是,各国应持续收集 AEFI 数据并确定因果关系,以此提高疫苗质量并保证疫苗安全。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nigerian Postgraduate Medical Journal
Nigerian Postgraduate Medical Journal MEDICINE, GENERAL & INTERNAL-
CiteScore
1.90
自引率
0.00%
发文量
52
期刊最新文献
An Exploratory Case-Control Study for Mitochondrial DNA G10398A in Bipolar I Disorder Patients with a Family History of Affective Disorders. Comparison of the Ultrasonography Features of the Breast in Women with Fibroadenoma and Those with Other Breast Lumps. Determination of Anterior Fontanelle Size among Apparently Healthy Term Newborns in North Central Nigeria. Exploring the Effect of Exercise versus Metformin on Insulin Resistance amongst Nigerians with Pre-diabetes: A Randomised Controlled Trial. Factors Associated with the Outcome of 2023 Diphtheria Outbreak in Jigawa State, Nigeria: A Retrospective Review of the Surveillance Data.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1